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ABSTRACT 
 
Introduction: Vertebroplasty is a minimally invasive technique in which 
percutaneous injection of bone cement under fluoroscopic guidance Percutaneous 
vertebroplasty (PVP) has been widely and successfully accepted in the treatment of 
osteoporotic and neoplastic vertebral compression fractures to control pain 
refractory to medical treatment. However, using of vertebroplasty as primary line 
treatment for traumatic, non-osteoporotic compression fractures still not widely 
accepted and considered a debatable issue. 
Patients and methods: This prospective comparative study was conducted at 
Neurosurgery department, Mansoura university hospital and Mansoura emergency 
hospital through the period between January 2015 and March 2016. 20 patients 
complaining of back pain due to single level thoracolumbar vertebral compression 
non-osteoprotic fractures were admitted to the study. Patients were divided into two 
groups 10 patients each, PVP group and conservative group. Outcome were assessed 
as regard pain improvement using Visual analogue scale VAS and quality of life using 
short form 36 scale (SF36).  
Results: Ten patients in the PVP group received Vertebroplasty, eight males (80%) and 
two females (20%) the age ranged from 29 to 62 years with mean age of 44.2+8.3 
(mean+SD) years. The conservative group included ten patients seven males (70%) 
and three females (30%) the age ranged from 31 to 64 years with mean age of 
45.1+9.2 (mean+SD) years. The level of injury ranged from D6 to L4. VAS and SF36 
results showed significant improvement in post injection results compared to 
preinjection and to the conservative group 
Conclusion: Percutaneous vertebroplasty is safe and effective procedure to improve 
pain and quality of life in non osteoprotic patients complaining of traumatic 
compression fractures of thoraco-lumar region it decreases pain, and provide early 
ambulation of patients which improve their quality of life without significant 
morbidity.  
 
INTRODUCTION 
Vertebral compression fractures (VCFs) represent a significant health 
care problem due to high incidence and their direct and indirect 
negative impact on quality of life, physical function, mental health and 
missed work hours as well as the burden on health care system 
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[114,21,25]. 
Vertebroplasty is a minimally invasive technique in 
which percutaneous injection of bone cement under 
fluoroscopic guidance into the cancellous bone of a 
vertebral body with the objective of bone 
augmentation [19]. Galibert et al. in 1987 were the 
first to describe and introduced Vertebroplasty, they 
used the technique for management of vertebral 
angiomas in seven patients [10]. Percutaneous 
vertebroplasty is a relatively safe, simple and 
commonly performed interventional procedure for 
the management of vertebral compression fractures 
[11].  
Percutaneous vertebroplasty (PVP) has been 
widely and successfully accepted in the treatment of 
osteoporotic and neoplastic vertebral compression 
fractures to control pain refractory to medical 
treatment [2,12, 15 18, 20,24, 25]. Taylor et al 2007 
published a systematic review and found that There 
is Level III evidence to support 
balloon kyphoplasty and vertebroplasty as effective 
therapies in the management of patients with 
symptomatic osteoporotic vertebral compression 
fractures refractory to conventional medical 
therapy.[23]. However, using of vertebroplasty as 
primary line treatment for traumatic, non-
osteoporotic compression fractures still not widely 
accepted and considered a debatable issue. 
Decrease fracture healing, risk of infection and 
effectiveness of alternative conservative and surgical 
options are raised as rejection points, while 
minimally invasiveness than surgery and 
improvement of pain and quality of life than medical 
treatment are assumed as advantages of the 
technique [5,6,7,8, 22].  
In this study, we compare the percutaneous 
vertebroplasty PVP and conservative medical 
treatment in the treatment of traumatic single level 
non-osteoprotic compression fractures. The 2 
groups were compared with respect to baseline pain, 
quality of life, hospital stay and follow up at 1 and 3 
months. 
 
PATIENTS AND METHODS 
This prospective comparative study was conducted 
at Neurosurgery department, Mansoura university 
hospital and Mansoura emergency hospital through 
the period between January 2015 and March 2016. 
20 patients complaining of back pain due to single 
level thoracolumbar vertebral compression fractures 
were admitted to the study. Patients were divided 
into two groups 10 patients each, PVP group and 
conservative group. The choice between the 2 
options was based primarily on patient’s preferences 
and, to some extent, on counseling by the 
neurosurgeon on charge, the first and second 
authors who did the PVP procedure were called for 
performing the procedure by the neurosurgeons on 
duty and didn’t involve in the process of decision 
making. 
 
Pre-operative evaluation 
Patients were assessed clinically by neurological and 
local examination. This aimed to exclude 
neurological deficit and identification of painful 
vertebra by local tenderness at the fracture site and 
detection of associated medical or surgical co-
morbidities. It aimed also at defining the degree of 
pain by Visual analogue scale (VAS) for pain 
assessment with 0 as no pain and 10 as the worst 
pain ever experienced. Short form 36 test (SF 36) for 
quality of life assessment [4]. 
Imaging studies included Plain X-ray radiography 
to detect the level, type and number of fractures, 
degree of collapse (relative vertebral body height) 
and the degree of kyphosis (vertebral wedge or local 
kyphotic angle). 
The relative vertebral height (RVH) was measured 
as the sum of the distance along the vertebral 
borders at the anterior, middle, and posterior 
locations of the fractured vertebral body in relation 
to the adjacent intact vertebral body as a reference. 
The kyphotic angle was determined by using the 
Cobb method as the angle between the superior and 
inferior endplates of the collapsed vertebral body. 
The relative heights of the fractured vertebrae and 
angle were assessed before and after vertebroplasty 
on a standard lateral radiograph, and assessed in the 
conservative group on admission then on discharge 
and during 1and 3 months follow up. CT scan with 
sagittal reconstruction was done for all patients to 
assess the type of fracture and the integrity of 
posterior wall of the vertebral body.  
Patients included to this study had traumatic 
fracture with intolerable pain who had a normal 
BMD t-score (-1 or higher) and their age above 18 
years old, compression fracture less than 50% of 
vertebral height, intact motor power, no or very small 
retropulsed segment. While pediatric patients, those 
having neurological deficit, fracture more than 50% , 
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unstable fracture with posterior or middle column 
disruption and compromise the canal, potential 
infection, bleeding tendency, oral anticoagulant, had 
previous spine surgery at same level, those have 
another painful disease of spine or pathological 
fractures either osteoporotic or neoplastic were 
excluded from our study. 
 
Procedure 
Patient was placed in prone position with translucent 
padding of the regions caudally and cranially from 
the fractured vertebra(e). oxygen mask was applied 
Oxygen saturation, blood pressure and heart rate 
are continuously monitored. sterile drapes were put 
after adequate sterilization of patient's back. 
Procedure is performed under local anaesthesia. 
Identification of the fractured level with the aid of 
fluoroscopy. (Figure 1). 
 
 
 
FIGURE 1: Vertebroplasty procedure: a- two injection needles at 
place b- during injection c- the needle and injector d- C-arm 
device at neurosurgery department operative room, Mansoura 
University hospital. 
 
 
 
FIGURE 2: Graph of median pain based on VAS score, on 
admission, on discharge 1 month and 3 months following 
vertebroplasty. VAS, visual analogue scale. 
 
 
FIGURE 3: Graph of mean quality of life based on SF36 scores on 
admission, 1 month and 3 months of both groups. 
 
 
 
FIGURE 4: Pre- and post-operative x-ray AP & lat view 
 
The fluoryscopy was manipulated till the fracture 
level centralized and both pedicle arches were 
identified on the antero-posterior (AP) image. Local 
anaesthesia was achieved by injection of Lidocaine 
1% solution using thin spinal needle by which we 
infiltrated the whole pathway from facet joint till 
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subcutaneous tissue. The position of the thin needle 
used for lidocaine injection determines the direction 
of the vertebroplasty needle tract during 
fluoroscopy. Under fluoroscopic guidance one 
(preferred) or two needles were introduced to 
pedicle then under guidance of lateral fluoroscopy 
image the needle was advanced till half of vertebra 
near midline which confirmed again by AP image. 
 During insertion of the needle, the bevelled tip was 
pointed laterally to gain easy access to the pedicle. 
After pedicle penetration, the bevelled side was 
rotated medially to avoid breaching of the medial 
pedicle wall. 
The PMMA cement (Exolent spine, ® Italy) was 
prepared and transferred to an injector. The air was 
eliminated from the system. After 2-4 minutes of 
cement mixing (depending on the viscosity of the 
cement and on the room temperature), the cement 
reached its proper viscosity (toothpaste-like), and is 
ready to be injected. The cement was then injected 
slowly and carefully under constant fluoroscopic 
imaging in order to achieve good filling of the 
intertrabecular space of the vertebral body. The 
injector is disconnected from the needle. the 
needle(s) was (were) removed with twist to separate 
the tip from the cement. 
 
Post procedure care: 
A post-procedural CT scan was performed to all 
cases to assess extent of bone cement and detection 
of any cement leak. Then the patient was placed in 
bed for transport to the ward Figure (5).  
 
 
FIGURE 5: Pre 
and post 
operative CT a- 
preoperative 
sagittal view b- 
postoperative 
axial view 
showed filling of 
the fractured 
 vertebra with 
bone cement 
with no leakage 
c- post 
operative 
sagittal view 
show 
restoration of 
vertebral height 
and angles. 
 
 
FIGURE 6: Unipedicular injection, cement cross the midline and 
small part of cement start to leak on the left side of vertebra. 
 
Follow up 
It was carried out at regular intervals; 2 weeks, 
1months and 3 months. In each time the patient 
were evaluated clinically for Neurological 
examination, pain by visual analogue scale, 
evaluation of quality of life by short form 36 test [3]. 
And radiographically by Plain X-ray. 
 
Statistical analysis: 
Data were analysed using the Statistical Package of 
Social Science (SPSS) program for Windows 
(Standard version 21). The normality of data was first 
tested with one-sample Kolmogorov-Smirnov test. 
Continuous variables were presented as mean ± SD 
(standard deviation) for parametric data and Median 
for non-parametric data. The two groups were 
compared with Student t test (parametric data) and 
Mann–Whitney test (non parametric data).  
 
Level of significance 
For all above mentioned statistical tests done, the 
threshold of significance is fixed at 5% level (p-value). 
The results were considered: 
 
• Non-significant when the probability of error is 
more than 5% (p > 0.05). 
• Significant when the probability of error is less 
than 5% (p ≤ 0.05). 
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The smaller the p-value obtained, the more 
significant are the result. 
 
RESULTS  
Twenty patients complaining of intractable back pain 
due to thoracolumbar vertebral compression 
fractures, and not responding to initial conservative 
measures and not associated with neurological 
affection. Ten patients in the PVP group received 
Vertebroplasty, Eight males (80%) and two females 
(20%) the age ranged from 29 to 62 years with mean 
age of 44.2+8.3 (mean+SD) years. six patients injured 
during fall from height while four sustained road 
traffic accidents. Unipedicular injection was 
performed for six vertebrae (60%), while bipedicular 
injection performed for four vertebrae (40%). The  
level of injected vertebra ranged from D8 to L4. The 
interval between trauma and injection ranged 3 to 12 
days mean was 4.6+1.8 the mean post injection 
hospital stay was 1.7 days ranged from 6 hours to 3 
days. The relative kyphotic angle was 10.42+3.8. The 
relative vertebral height was 77+7mm  
The conservative group included ten patients 
seven males (70%) and three females (30%) the age 
ranged from 31 to 64 years with mean age of 
45.1+9.2 (mean+SD) years. 5 patients injured during 
fall from height while 5 sustained road traffic 
accidents. The level of fractured vertebra ranged 
from D6 to L3. The relative kyphotic angle was 
10.17+3.5. The relative vertebral height was 
78+2mm.
 
TABLE 1: Comparison between both group regarding data on admission. 
 
 
Vertebral 
height 
Kyphotic angle age 
Gender   
p- value 
M F  
Conservative 78+2.7 10.17+3.5 45.1+9.2 7 3 
>0.05 
PVP 78+2.7 10.42+3.8 44.2+8.3 8 2  
 
 
TABLE 2: Comparison between Conservative and PVP groups regarding VAS preoperative and at different follow up periods. 
 
VAS Conservative (n=10) PVP (n=10) 
Mann Whitney 
test 
p- value 
Admission  
Median (Min-Max) 
7 (4-9) 7 (4-9) 0.194 0.846 
VAS at discharge 
Median (Min-Max) 
5 (4-7) 3 (1-6) 2.778 0.005* 
VAS after 1m 
Median (Min-Max) 
4 (2-5) 2 (0-4) 2.625 0.009* 
VAS after 3m 
Median (Min-Max) 
2 (0-2) 1 (0-1) 2.109 0.035* 
 
*significant p <0.05 
 
Table 2 showed the results of VAS on admission the 
differences between both group was statistically 
insignificant (P=0.846) The pain showed statically 
significant improvement in PVP group patients from 
preoperative VAS and compared to conservative 
group the level of significance was highest on time of 
discharge(p=0.005) and gradually decreased till 3 
months (p=0.035). 
In the PVP group Preoperative VAS ranged from 4 to 
9(0% no pain, 0% mild, 10% uncomfortable, 40% 
distressing, 45% horrible & 5%worst). on discharge 
VAS ranged between 1 to 6(0% no pain, 40% mild, 
45% uncomfortable, 10% distressing, 5% horrible & 
0% worst). Table 1 
Comparing unipedicular versus bipedicular 
techniques results, it is found that no significant 
difference between improvement of VAS between 
both techniques Table 3. showed results of VAS in 
unipedicular and bipedicular techniques. 
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TABLE 3: Comparison between unipedicular and bipedicular PVP regarding VAS preoperative and at different follow up periods. 
 
VAS 
Unilateral PVP 
(n=6) 
Bilateral PVP (n=4) 
Mann Whitney 
test 
p- value 
Pre-injection 
Median (Min-Max) 
7 (5-8) 7 (4-9) 0.441 0.659 
VAS at discharge 
Median (Min-Max) 
3 (1-3) 4 (2-6) 1.453 0.146 
VAS after 1m 
Median (Min-Max) 
2 (0-3) 2 (1-4) 0.775 0.438 
VAS after 3m 
Median (Min-Max) 
1 (0-1) 1 (0-1) 0.267 0.789 
 
 
The mean preoperative SF 36 test score was 
55.10±12.57 pointsin conservative group versus 
59.80±12.16 in PVP group (p=0.407). While the 1 
month after discharge mean SF 36 test score was 
65.1±10.37 points for conservative group while was 
80.70±4.13 (p<0.001). on three months follow up 
SF36 score was 79.10 ± 6.84 and 86.00 ± 6.16 
respectively. The improvement outcome of 
postoperative values compared with preoperative SF 
36 test score was found to be statistically significant 
(P<0.001). table 4. As the results of VAS the difference 
between unipedicular and bipedicular injection in 
improving quality of on S36 score were insignificant 
Table 5 Comparing unipedicular versus bipedicular 
techniques results, the difference was found to be 
statistically insignificant. Table 5. 
There was no mortality in both groups. We had only 
two cases of cement leakages one case of 
asymptomatic vascular extravasation of cement and 
another patient in whom cement leaked into upper 
disc space.
 
TABLE 4: Comparison between Conservative and PVP groups regarding SF36 pre injection and at different follow up periods. 
 
SF36 
Conservative 
(n=10) 
PVP (n=10) Student t-test p- value 
Pre-injection 
Mean ± SD 
55.10±12.57 59.80±12.16 0.850 0.407 
SF36 after 1m 
Mean ± SD 
65.1±10.37 80.70±4.13 4.29 <0.001* 
SF 36 after 3m 
Mean ± SD 
79.10±6.84 86.00±6.16 2.370 0.029* 
 
TABLE 5: Comparison between unilateral and bilateral PVP regarding SF36 preoperative and at different follow up periods. 
 
SF36 
Unilateral PVP 
(n=6) 
Bilateral PVP 
(n=4) 
Student t-test p- value 
Pre-injection 
Mean ± SD 
55.67±11.39 66.00±11.91 1.381 0.205 
SF36 after 1m 
Mean ± SD 
80.00±4.09 81.75±4.57 0.633 0.544 
SF 36 after 3m 
Mean ± SD 
83.50±5.36 89.75±5.91 1.738 0.120 
 
Table 5 studies addressed non ostoprotic traumatic fractures 
 461 Improved pain and quality of life outcomes after percutaneous vertebroplasty 
Author Study design  Type of fracture Number of patients Year  
Chen and Lee Case report Burst  1 2004 
Chen and Lee Case series Burst  6 patients 2004 
Amoretti et al Case series Burst 5 patients 2005 
Huet et al Case series Burst 12 2005 
Szekely et al Case report Burst  1 2009 
Knavel et al Retrospective review compression 15 patients 2009 
Szekely Gy Case series Compression  15 patients 2012 
Elnoamany  Case series compression 23 patients 2015 
DISCUSSION 
Conservative management, surgical fixation and 
vertebroplasty are available treatments options for 
traumatic VCFs. Medical treatment includes rest, 
thoraco-lumar orthosis and analgesic is indicated in 
case no neurological deficit, no any signs of instability 
and kyphotic angle less than 20 degrees and less 
than 50% vertebral height loss, which are the same 
indications for percutenous vertebroplasty. For 
vertebroplasty there is another relative indication 
which is the integrity of posterior wall of vertebral 
body [14,17].  
Surgical intervention is not usually the first line of 
therapy and mostly is necessary if the kyphosis is 
above 20 degrees to prevent corporeal collapse and 
prevent subsequent neurological disorders or low 
back pain. The signs of instability like involvement of 
the posterior wall, disruption of the spinal arch or 
interpedicular olisthesis are indication for surgical 
intervention [1]. 
Nowadays vertebroplasty become a popular 
procedure for management of refractory pain in 
osteoprotic compression fractures and pathological 
fractures. However, there is a debat about its efficacy 
in pain relief, quality of life improvement, using it in 
traumatic cases and its complications. Few reports in 
litreture were addressed the implication of 
vertebroplasty in management of the non-
osteoprotic traumatic VCFs [3, 6, 7, 9, 14, 21, 22], two 
of them are case reports and the others are limited 
sample cohort studies. Table (5) Up to our knowlage, 
no published comparative study compared the 
outcome of vertebroplasty to that of conservative 
management in patients suffering traumatic non 
osteoprotic thoraco-lumbar VCFs. This study is 
unique in comparing both treatment modalities in 
control of pain early mobilization and improving 
quality of life. 
Our results showed that vertebroplasty was 
effective in reducing pain in all of the vertebroplasty 
group's patients within a very short period of time. 
VAS scores obtained on time of patient discharge, 1 
month and 3 months after vertebroplasty from our 
10 patients of the PVP group showed significant pain 
relief. And when compared to the VAS scores of the 
conservative group patients, there were statistically 
significant superiority to the vertebroplasty group. 
Pain relief was rapid and marked. This improvement 
was maintained and continued to improve through 
the whole follow up period and didn’t decline by 
time.  
Our results of pain improvement are supporting 
the result of Szekely et al in their 15 patients' report; 
all of them showed more than 5 points improvement 
of VAS [22]. El noamany reported injection of 29 
vertebrae in 23 patients of non-osteoporotic VCFs, all 
of them showed improved pain scores both on rest 
and movement, the improvement started 2 hours 
post injection and continue during follow up, he 
advocated PVP as first line treatment of VCFs[9]. 
Chen and Lee performed PVP for management of 
traumatic Thoracolumbar spine bursting fractures 
with statistically significant improvement of pain 
their six patients[6]. Amoretti et al reported 5 
patients of stable burst fracture percutaneous 
vertebroplasty was done under both fluoroscopy 
and CT guidance, pain improved in 4 out of their 5 
patients [3]. 
The difference between both groups was 
statistically significant in the time of discharge and 
one month follow up visit and decline in the 3 
months follow up visit. There were no significant 
differences in these Improvements due to the 
etiology of the fracture or due to the approach used 
wither unipedicular or bipedicular or the amount of 
cement used.  
Kallmes et al and Buchbinder et al [5,16] 
published two randomized trials in 2009, they 
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reported that there is no beneficial effect of 
vertebroplasty compared with a sham procedure ( 
placebo surgery) in patients with painful 
osteoporotic vertebral fractures, at 1 week or 1 or 3 
months after treatment. No significant differences 
between groups were seen in the primary outcome 
of overall pain at 3 months. Despite their population 
were osteoprotic, we have many concerns about this 
results, as in our study pain improvement was 
significant which match with most of studies talking 
about pain improvement following PVP with a 
variable degree of pain improvement but in this 
study noting that there is no difference between PVP 
and sham procedure is questionable. 
Despite small sample size, we found no statistical 
significance between the six patients received 
unipedicular injection and the 4 patients received 
bipedicular injection as regard improving VAS scores 
and quality of life on SF36. The same conclusion was 
announced by two studies, Knavel et al. [17] 
concluded from their retrospective study that, 
hemivertebroplasty in which cement is instilled in 
only one half of the vertebral body was as efficacious 
as bilateral cement infusion [17]. The results of 
ELnoamany study on non-osteoprotic VCFs 
confirmed Knavel’s study results, since it showed no 
statistically significant differences in pain or quality 
of life scores, between hemivertebroplasty and 
bilateral vertebral filling [9,l7] which may be partially 
explained by increase the hardness of non 
osteoprotic bone. In our opinion, This piece of 
information is significant because it support the 
minimally invasive nature of the procedure which 
could be performed optimally through on side 
injection, and it facilitate performing vertebroplasty 
by local anesthetic infiltration rather than sedative 
anesthesia and this will encourage patients for taking 
their decisions and lastly it will decrease cost 
especially in poor countries. 
Pain relief was obviously reflected on the quality 
of life of the patient and his/her resumption of social 
activities which were obvious in short form 36 test 
score improvements. as the short form 36 test SF36 
take a survey for last month we found it difficult to 
be applied on time of discharge and that is why we 
applied it in one and three months follow up visit. 
The significant improve in SF36 score results in the 
vertebroplasty group between pre injection and 
follow up and between the vertebroplasty group and 
conservative group support the results accumulated 
from many previous studies that concluded 
improvement of quality of life after cement injection 
for compression fractures either in osteoporotic 
patients[4, 12,13,18] or in traumatic non osteoprotic 
VCFs[ 3,6,9, 14, 22] but may be our results is the first 
to compare the conservative treatment to 
vertebroplasty in head to head prospective 
randomized study that showed statistical significant 
improvement in quality of life in the vertebroplasy 
group.  
A comparison of the pre and post vertebroplasty 
scores in the various SF-36 domains has shown a 
significant and clinically relevant increase in 
summary scores, thereby indicating a significant 
overall increase in the quality of life. During the two 
weeks after vertebroplasty significant improvement 
was seen only in the domains of physical function, 
which is known to have the highest correlation with 
physical faculties and pain, reflecting the results of 
the numerical pain score. The role physical and role 
emotional domains showed an obvious, non-
significant decrease in the first month, probably due 
to general post-treatment role-inhibiting behavior. 
There was a significant improvement in summary 
scores of SF-36 domains at follow-up at one and 
three months in our series. 
It has great potential to avoid various problems 
associated with prolonged bed-rest, including high 
medical expense used for analgesics and other 
medications, deterioration in bone density and 
function of the musculoskeletal system and 
progression of dementia in elderly patients. 
Persistent back pain may also cause psychological 
and sleep disorders.  
 
CONCLUSION 
Percutenous vertebroplasty is safe and effective 
procedure to improve pain and quality of life in non 
osteoprotic patients complaining of traumatic 
compression fractures of thoraco-lumar region it 
decreases pain, and provide early ambulation of 
patients which improve their quality of life without 
significant morbidity. 
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ABBREVIATIONS 
BMD: Bone Mineral Density.  
CT: Computerized Tomography.  
PVP: Percutaneous Vertebroplasty 
PMMA: Poly Methyl Methacrylate .  
RVH: Relative Vertebral Height 
SF 36: Short Form 36  
VAS: Visual Analog scale 
VCF1: Vertebral Compression Fracture.  
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